These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32349101)

  • 1. ASSESSMENT OF HYPERREFLECTIVE FOCI AFTER BEVACIZUMAB OR DEXAMETHASONE TREATMENT ACCORDING TO DURATION OF MACULAR EDEMA IN PATIENTS WITH BRANCH RETINAL VEIN OCCLUSION.
    Do JR; Park SJ; Shin JP; Park DH
    Retina; 2021 Feb; 41(2):355-365. PubMed ID: 32349101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion.
    Moon SY; Cho KH; Woo SJ; Park SP; Kim YK
    Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
    Kim M; Jeong S; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
    Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
    Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intravitreal bevacizumab and dexamethasone implant for the treatment of macula oedema associated with branch retinal vein occlusion.
    Kim M; Lee DH; Byeon SH; Koh HJ; Kim SS; Lee SC
    Br J Ophthalmol; 2015 Sep; 99(9):1271-6. PubMed ID: 25777815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PERIPHERAL ISCHEMIC RETINAL PHOTOCOAGULATION IN ADDITION TO INTRAVITREAL BEVACIZUMAB VERSUS INTRAVITREAL BEVACIZUMAB ALONE FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION: A Randomized Double-Masked Controlled Clinical Trial.
    Nourinia R; Emamverdi M; Ramezani A; Amizadeh Y; Khorshidifar M; Behnaz N; Safi S
    Retina; 2020 Jun; 40(6):1110-1117. PubMed ID: 31157710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
    Tang F; Qin X; Lu J; Song P; Li M; Ma X
    Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.
    Ozkaya A; Tarakcioglu HN; Tanir I
    Optom Vis Sci; 2018 Dec; 95(12):1149-1154. PubMed ID: 30451802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of combined bevacizumab/targeted photocoagulation vs bevacizumab alone for macular oedema in ischaemic branch retinal vein occlusions.
    Tomomatsu Y; Tomomatsu T; Takamura Y; Gozawa M; Arimura S; Takihara Y; Inatani M
    Acta Ophthalmol; 2016 May; 94(3):e225-30. PubMed ID: 25989706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
    Hwang HS; Chae JB; Kim JY; Kim DY
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5958-5967. PubMed ID: 29183041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-Four-Month Results of Intravitreal Bevacizumab in Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Tsagkataki M; Papathomas T; Lythgoe D; Kamal A
    Semin Ophthalmol; 2015; 30(5-6):352-9. PubMed ID: 24875368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab treatment for acute branch retinal vein occlusion accompanied by subretinal hemorrhage.
    Zhao L; Li B; Feng K; Han L; Ma Z; Liu Y
    Curr Eye Res; 2015 Jul; 40(7):752-6. PubMed ID: 25330134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
    Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
    Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion.
    Kang JW; Lee H; Chung H; Kim HC
    Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1413-21. PubMed ID: 24577742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison.
    Gado AS; Macky TA
    Clin Exp Ophthalmol; 2014; 42(7):650-5. PubMed ID: 24612095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The additive effect of intravitreal dexamethasone combined with bevacizumab in refractory diabetic macular edema.
    Karimi S; Karrabi N; Hassanpour K; Amirabadi A; Daneshvar K; Nouri H; Abtahi SH
    J Fr Ophtalmol; 2023 Nov; 46(9):1019-1029. PubMed ID: 37481454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OUTER RETINAL LAYER CHANGES AFTER DEXAMETHASONE IMPLANT FOR CENTRAL RETINAL VEIN OCCLUSION.
    Battaglia Parodi M; Iacono P; Scaramuzzi M; Bandello F
    Retina; 2017 Oct; 37(10):1888-1895. PubMed ID: 28030428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.